Speakers

Your Full 2012 Expert Speaker Faculty across Both Events

25+ world-leading international experts…


Manfred Kansy till recently was heading the Structure/Property Effect Relationships group at F. Hoffmann-La Roche Ltd. Non-Clinical Safety, Basel, Switzerland. He is currently taking over another important task in the NCS organization. The S/PER team concentrated on compound profiling, data interpretation and in silico tool development in the lead selection and optimization phases of drug discovery. Major focus of the multidisciplinary team was directed to more predictive safety in silico prediction and ranking tools, allowing an early identification of potential drug safety liabilities via computational methods.

Manfred Kansy
Associate Director, Non-Clinical Safety
Roche


Jens-Uwe Peters is a medicinal chemist in the Discovery Chemistry department of F. Hoffmann-La Roche Ltd in Basel, Switzerland. Over the last 10 years, he has been involved in numerous drug discovery projects, including several projects in which pharmacological promiscuity was a key issue. He has also contributed to an Early Safety Profiling initiative, in which safety panel profiling was an important aspect.

Jens-Uwe Peters
Principle Scientist
Roche

[ Register Now ]